Efficacy and safety of mitazalimab in combination with mFOLFIRINOX in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): An interim analysis of the optimize-1 phase 1b/2 study

被引：0
|
作者：
Prenen, Hans
Borbath, Ivan
Paula Geboes, Karen
Alexandre Cassier, Philippe
Lambert, Aurelien
Mitry, Emmanuel
Macarulla, Teresa
Taieb, Julien
Blanc, Jean-Frederic
Feliu Batlle, Jaime
Rodriguez Garrote, Mercedes
Pazo Cid, Roberto A.
Valladares-Ayerbes, Manuel
Nordbladh, Karin
Enell Smith, Karin
Ellmark, Peter
Carlsson, Malin
Pico de Coana, Yago
Vijay Ambarkhane, Sumeet
Van Laethem, Jean-Luc
机构：
[1] Univ Antwerp, Ctr Oncol Res CORE, Integrated Personalized & Precis Oncol Network IP, Antwerp, Belgium
[2] Clin Univ St Luc, Woluwe St Lambert, Belgium
[3] Ghent Univ Hosp, Div Digest Oncol, Dept Gastroenterol, Ghent, Belgium
[4] Ctr Leon Berard, Lyon, France
[5] Inst Cancerol Lorraine, Vandoeuvre Les Nancy, France
[6] Inst Paoli Calmettes, Marseille, France
[7] Vall DHebron Univ Hosp, Vall DHebron Inst Oncol VHIO, Barcelona, Spain
[8] Georges Pompidou European Hosp, Paris, France
[9] CHU Bordeaux, Hop Haut Leveque, Serv Hepato Gastroenterol & Oncol Digest, Bordeaux, France
[10] Hosp Univ La Paz, Madrid, Spain
[11] Hosp Univ Ramon y Cajal, Madrid, Spain
[12] Hosp Univ Servet, Zaragoza, Spain
[13] Virgen Rocio Univ Hosp, Seville, Spain
[14] Alligator Biosci AB, Lund, Sweden
[15] Univ Libre Bruxelles, Hop Erasme, Brussels, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4139
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Open-label, multicenter, phase 1b/2 study of rebastinib in combination with paclitaxel to assess safety and efficacy in patients with advanced or metastatic endometrial cancer.
    Janku, Filip
    Hamilton, Erika P.
    Mathews, Cara Amanda
    Chu, Christina
    Diamond, Jennifer Robinson
    Hays, John L.
    Arend, Rebecca Christian
    Cristofanilli, Massimo
    Jewell, Andrea
    Reichmann, William
    Kuida, Keisuke
    Achour, Haroun
    Ruiz-Soto, Rodrigo
    Richardson, Debra L.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [42] Phase 1b/2 study of rebastinib (DCC-2036) in combination with paclitaxel: Preliminary safety, efficacy, pharmacokinetics and pharmacodynamics in patients with advanced or metastatic solid tumors
    Janku, Filip
    Birrer, Michael
    Richardson, Debra
    Chu, Christina
    Goel, Sanjay
    Su, Ying
    Matin, Bahar
    Kuida, Keisuke
    Ruiz-Soto, Rodrigo
    Hamilton, Erika Paige
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [43] Selected subgroup analyses of liposomal irinotecan (nal-IRI) in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) in the global NAPOLI-1 phase III trial
    Macarulla Mercade, T.
    Lee, K.
    Lakatos, G.
    Wang-Gillam, A.
    Chen, L.
    Mirakhur, B.
    De Jong, F.
    ANNALS OF ONCOLOGY, 2018, 29
  • [44] A phase 1b study of andecaliximab in combination with S-1 plus platinum in Japanese patients with gastric adenocarcinoma
    Ooki A.
    Satoh T.
    Muro K.
    Takashima A.
    Kadowaki S.
    Sakai D.
    Ichimura T.
    Mitani S.
    Kudo T.
    Chin K.
    Kitano S.
    Thai D.
    Zavodovskaya M.
    Liu J.J.
    Boku N.
    Yamaguchi K.
    Scientific Reports, 12 (1)
  • [45] A phase 1b/2 study of the combination of the IDO pathway inhibitor indoximod and temozolomide for adult patients with temozolomide-refractory primary malignant brain tumors: Safety analysis and preliminary efficacy of the phase 1b component.
    Colman, Howard
    Mott, Frank
    Spira, Alexander I.
    Johnson, Theodore S.
    Zakharia, Yousef
    Vahanian, Nicholas N.
    Link, Charles J.
    Kennedy, Eugene Paul
    Sadek, Ramses F.
    Munn, David
    Rixe, Olivier
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [46] Phase 1b/2 Study of the Efficacy and Safety of Sonidegib (LDE225) in Combination with Ruxolitinib (INC424) in Patients with Myelofibrosis
    Gupta, Vikas
    Harrison, Claire N.
    Hasselbalch, Hans
    Pieri, Lisa
    Koschmieder, Steffen
    Cervantes, Francisco
    Bao, Weichao
    Kalambakas, Stacey
    Atienza, Edric
    Gopalakrishna, Prashanth
    Heidel, Florian H.
    BLOOD, 2015, 126 (23)
  • [47] Safety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma
    Cote, Gregory M.
    Haddox, Candace L.
    Choy, Edwin
    Merriam, Priscilla A.
    Mazzola, Emanuele
    Venkataraman, Vinayak
    Alcindor, Thierry
    Wagner, Andrew J.
    Demetri, George D.
    George, Suzanne
    CLINICAL CANCER RESEARCH, 2024, 30 (13) : 2702 - 2708
  • [48] Interim Analysis of the Randomized Phase 1b/3 Study Evaluating the Safety and Efficacy of Tazemetostat Plus Lenalidomide and Rituximab in Patients with Relapsed/Refractory Follicular Lymphoma
    Batlevi, Connie Lee
    Park, Steven I.
    Nastoupil, Loretta
    Phillips, Tycel
    Amengual, Jennifer E.
    Andorsky, David
    Campbell, Philip
    McKay, Pamela
    Pagel, John M.
    Leonard, John P.
    Yang, Jay
    O'Connor, Heather
    Hamlett, Anthony
    Adib, Deyaa
    Morschhauser, Franck
    BLOOD, 2021, 138
  • [49] A phase 2, open-label, multicenter study of durvalumab (MEDI4736) tremelimumab in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC): ALPS.
    O'Reilly, Eileen Mary
    Oh, Do-Youn
    Lee, Myung Ah
    Dhani, Neesha
    Armstrong, Jon
    Belli, Riccardo
    Ferro, Salvatore
    Ben, Yong
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] A Phase 1b Dose-Escalation Study of Carotuximab in Combination with Nivolumab in Patients with Metastatic NSCLC
    Robert, F.
    Gray, J. E.
    Trigeiro, A.
    Adams, B.
    Theuer, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S725 - S726
12345